COWN Stock Recent News

Restaurant Business Magazine's Jonathan Maze and TD Cowen's Andrew Charles, join McDonald's extending its value meal and the state of the quick service and fast casual sectors.

LOUISVILLE, Ky.--(BUSINESS WIRE)--Brown-Forman Corporation (NYSE: BFA, BFB) announced today that President and Chief Executive Officer Lawson Whiting will participate in TD Cowen's 2nd Annual Sip, Snack & Scrub Summit on September 17, 2024. Brown-Forman's virtual “fireside chat” will begin at approximately 11:00 a.m. (EDT) and will be available as a webcast on the Brown-Forman website at brown-forman.com on the Investors/Events & Presentations page. A replay will be available on the Bro.

CORAL GABLES, Fla.--(BUSINESS WIRE)--Fresh Del Monte Produce Inc. Announces Participation in TD Cowen's 2nd Annual Sip, Snack & Scrub Summit.

Andrew Charles, TD Cowen research analyst, joins 'Money Movers' to discuss the similarities between Brian Niccol's position with Starbucks now and Chipotle some years ago, how Niccol was able to impact Chipotle, and more

Dan Brennan, senior analyst at TD Cowen, joins CNBC's 'The Exchange' to discuss his price target on Tempus, AI in diagnostics, and more.

Ritu Baral, TD Cowen Sr. Biotechnology Analyst, joins 'Closing Bell Overtime' to talk Sarepta's approval from the FDA for its Duchenne gene therapy and how it drove the stock to its best trading day in a year.

SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that Faraz Ali, Chief Executive Officer, will participate in the TD Cowen Genetic Medicines & RNA Summit on Friday, June 21, 2024, at 11:20 am ET.

CARLSBAD, Calif. , June 17, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in a fireside chat at the virtual TD Cowen Genetic Medicines & RNA Summit on Thursday, June 20, 2024.

CAMBRIDGE, Mass., June 14, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in a fireside chat at the virtual 2024 TD Cowen Genetic Medicines & RNA Summit on Friday, June 21st, 2024 at 1:50 p.m. ET.

The Toronto-Dominion Bank (NYSE:TD ) TD Cowen's 8th Annual Future of the Consumer Conference June 6, 2024 8:30 AM ET Company Participants Riaz Ahmed - Group Head, Wholesale Banking Conference Call Participants Mario Mendonca - TD Cowen Mario Mendonca Good morning, everyone, and thank you for joining us. Riaz, a special thank you to you to get us -- helping us get started on this conference.